小儿肺热清颗粒联合丙酸氟替卡松对小儿支气管哮喘患者的临床疗效
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical effects of Xiao'er Feireqing Granules combined with fluticasone propionate on pediatric bronchial asthma patients
  • 作者:杜文琼 ; 彭小利 ; 朱晓琴 ; 高英 ; 宋生青
  • 英文作者:DU Wen-qiong;PENG Xiao-li;ZHU Xiao-qin;GAO Ying;SONG Sheng-qing;Department of Comprehensive Health Care,Qinghai Provincial Women and Children Hospital;
  • 关键词:小儿肺热清颗粒 ; 丙酸氟替卡松 ; 小儿支气管哮喘
  • 英文关键词:Xiao'er Feireqing Granules;;fluticasone propionate;;pediatric bronchial asthma
  • 中文刊名:ZCYA
  • 英文刊名:Chinese Traditional Patent Medicine
  • 机构:海省妇女儿童医院综合保健科;
  • 出版日期:2019-02-20
  • 出版单位:中成药
  • 年:2019
  • 期:v.41
  • 语种:中文;
  • 页:ZCYA201902014
  • 页数:4
  • CN:02
  • ISSN:31-1368/R
  • 分类号:75-78
摘要
目的研究小儿肺热清颗粒联合丙酸氟替卡松对小儿支气管哮喘患者的临床疗效。方法 120例患者随机分为对照组和实验组,每组60例,对照组给予丙酸氟替卡松,实验组在对照组基础上加用小儿肺热清颗粒,疗程14 d。然后,检测总有效率、临床症状消失时间、血清炎性因子(TNF-α、hs-CRP、IL-4)水平、肺功能指标(FEV1、PEFR、FEV1/FVC)、不良反应发生率。结果治疗后,实验组总有效率显著高于对照组(P<0. 05),临床症状消失时间显著缩短(P<0. 05); 2组TNF-α、hs-CRP、IL-4水平、FEV1、PEFR、FEV1/FVC显著改善(P<0. 05),以实验组更明显(P<0. 05); 2组不良反应发生率无显著差异(P>0. 05)。结论小儿肺热清颗粒联合丙酸氟替卡松可改善小儿支气管哮喘患者血清炎性因子水平和肺功能,临床疗效和安全性良好。
        AIM To study the clinical effects of Xiao'er Feireqing Granules combined with fluticasone propionate on pediatric bronchial asthma patients. METHODS One hundred and twenty patients randomly assigned into control group and trial group,60 cases in each group,went on 14-day intervention of fluticasone propionate( control group),or Xiao'er Feireqing Granules+fluticasone propionate( trial group). Subsequently,total effective rate,clinical symptom disappearing time,serum inflammatory factors( TNF-α,hs-CRP,IL-4) levels,lung function indices( FEV1,PEFR,FEV1/FVC),adverse reaction incidence rate were detected. RESULTS The trial group demonstrated significantly higher total effective rate than the control group( P < 0. 05),and markedly shortened clinical symptom disappearing time( P<0. 05). Both groups shared obvious post-treatment improvements in TNF-α,hs-CRP,IL-4 levels,FEV1,PEFR,FEV1/FVC( P<0. 05),especially for those in the trial group( P<0. 05);yet no significant difference in adverse reaction incidence rate existed in the two groups( P> 0. 05).CONCLUSION Xiao 'er Feireqing Granules combined with fluticasone propionate may be of good clinical efficacy and safety for the management of pediatric bronchial asthma patients due to their improvement in serum inflammatory factors levels and lung function.
引文
[1]董宗祈.小儿过敏性哮喘的发病机制及其治疗[J].实用儿科临床杂志,2000,15(3):174-176.
    [2]邓伟吾.吸入性糖皮质激素治疗支气管哮喘[J].临床肺科杂志,2009,14(2):143-144.
    [3]周新,郭海英.丙酸氟替卡松及其在哮喘治疗中的应用进展[J].国外医药(合成药生化药制剂分册),2000,21(2):76-78.
    [4]刘丹.清肺止咳颗粒的药效学研究[D].杨凌:西北农林科技大学,2014.
    [5]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138.
    [6]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
    [7]金玉子,张玉峰,唐颖.玉屏风颗粒联合硫酸沙丁胺醇治疗小儿支气管哮喘的临床研究[J].现代药物与临床,2016,31(2):190-194.
    [8]李凌,张志红,张惠琴,等.丙酸氟替卡松联合布地奈德治疗小儿支气管哮喘的临床研究[J].现代药物与临床,2017,32(10):1899-1903.
    [9]杜芬芬,霍璇,冯玥,等.小儿肺热咳喘颗粒清热解毒、止咳平喘作用研究[J].药物评价研究,2017,40(12):1706-1710.
    [10]王文亮.玉屏风散加减治疗小儿支气管哮喘临床研究[J].中国当代医药,2010,17(18):93-94.
    [11]杨少英,吕建军.中西医结合治疗小儿支气管哮喘临床分析[J].当代医学,2009,15(13):147,102.
    [12]徐丽,贾连群,张哲,等.小儿支气管哮喘的中西医病机及治疗[J].中华中医药学刊,2018,36(3):552-554.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.